A Randomized Trial of Dolutegravir Plus Darunavir/ Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes

  1. Santos, J.R.
  2. Domingo, P.
  3. Portilla, J.
  4. Gutiérrez, F.
  5. Imaz, A.
  6. Vilchez, H.
  7. Curran, A.
  8. Valcarce-Pardeiro, N.
  9. Payeras, A.
  10. Bernal, E.
  11. Montero-Alonso, M.
  12. Yzusqui, M.
  13. Clotet, B.
  14. Videla, S.
  15. Moltó, J.
  16. Paredes, R.
Revue:
Open Forum Infectious Diseases

ISSN: 2328-8957

Année de publication: 2023

Volumen: 10

Número: 11

Type: Article

DOI: 10.1093/OFID/OFAD542 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus